5-140114310-TGGCGGCGGC-TGGCGGCGGCGGCGGC
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_005859.5(PURA):c.141_146dup(p.Gly48_Gly49dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000612 in 1,291,080 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000086 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000058 ( 0 hom. )
Consequence
PURA
NM_005859.5 inframe_insertion
NM_005859.5 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.895
Genes affected
PURA (HGNC:9701): (purine rich element binding protein A) This gene product is a sequence-specific, single-stranded DNA-binding protein. It binds preferentially to the single strand of the purine-rich element termed PUR, which is present at origins of replication and in gene flanking regions in a variety of eukaryotes from yeasts through humans. Thus, it is implicated in the control of both DNA replication and transcription. Deletion of this gene has been associated with myelodysplastic syndrome and acute myelogenous leukemia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 5-140114310-T-TGGCGGC is Benign according to our data. Variant chr5-140114310-T-TGGCGGC is described in ClinVar as [Likely_benign]. Clinvar id is 542077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 12 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PURA | NM_005859.5 | c.141_146dup | p.Gly48_Gly49dup | inframe_insertion | 1/1 | ENST00000331327.5 | NP_005850.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PURA | ENST00000331327.5 | c.141_146dup | p.Gly48_Gly49dup | inframe_insertion | 1/1 | NM_005859.5 | ENSP00000332706 | P1 | ||
PURA | ENST00000505703.2 | c.141_146dup | p.Gly48_Gly49dup | inframe_insertion | 2/2 | 3 | ENSP00000498560 | |||
PURA | ENST00000651386.1 | c.141_146dup | p.Gly48_Gly49dup | inframe_insertion | 2/2 | ENSP00000499133 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000860 AC: 12AN: 139490Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
12
AN:
139490
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000685 AC: 2AN: 29190Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 18126
GnomAD3 exomes
AF:
AC:
2
AN:
29190
Hom.:
AF XY:
AC XY:
0
AN XY:
18126
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000582 AC: 67AN: 1151502Hom.: 0 Cov.: 31 AF XY: 0.0000591 AC XY: 33AN XY: 558774
GnomAD4 exome
AF:
AC:
67
AN:
1151502
Hom.:
Cov.:
31
AF XY:
AC XY:
33
AN XY:
558774
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000860 AC: 12AN: 139578Hom.: 0 Cov.: 32 AF XY: 0.0000884 AC XY: 6AN XY: 67850
GnomAD4 genome
AF:
AC:
12
AN:
139578
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
67850
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 09, 2022 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
PURA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 23, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at